Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
January 20, 2012

Poll Results Point to Personal Sequencing Platforms Entering the Clinic This Year

  • Personal sequencing platforms will enter the clinical diagnostic arena this year, a majority of voters on a recent GEN poll predict. While 56.4% of respondents anticipate that sequencing instrument companies will continue to develop more user-friendly and cheaper technology, focused on the benchtop and clinical markets, 35.9% do not believe success will be seen this year and 7.7% undecided.

    Research, discovery, and development applications still comprise the largest sequencing markets, but the largest market opportunity by far is in personal genomics and clinical diagnostics. Those segments are expected to reach $541 million by 2015 from $15.5 million in 2010. Recent advancements in next-generation sequencing have resulted in the advent of so-called personal genome machines. However, companies aiming at the clinical space will need to gain regulatory approval for their use in clinical laboratory diagnostics.

Related content

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.